Atlas.
Sign inStart free trial
PRCTNASDAQ · US

PROCEPT BioRobotics Corp

Technology · Surgical & Medical Instruments & Apparatus

TechnologySurgical & Medical Instruments & Apparatus
CEO
Larry L. Wood
Founded
—
IPO Date
—
HQ
San Jose, CA, United States
Exchange
NASDAQ
Employees
n.a.

Share Price Performance

$23.47 ▼ 23.7%
Last (1 Jul 2026) · $23
Period High · $34.71
Period Low · $0.00
52W: $23.47 – $60.06

Key Metrics

Share Price
$23.47
+3.9% today
Market Cap
$1.3B
P / E
—
EV / Revenue
3.5x
Revenue Growth
+37.2%
year-on-year
Gross Margin
+63.7%
Enterprise Value
$1.1B
52W High
$60.06
52W Low
$0.00
Avg Volume
1.5M
daily

Sources: SEC filings · Market data as of Jul 6, 2026

Shareholders' Structure
12 known institutional holders·$295M total on record·2026-Q1
BlackRock, Inc.
7.8%·$109M
State Street Corp
2.7%·$38M
Fmr LLC
2.6%·$37M
Geode Capital Management, LLC
2.4%·$34M
Point72 Asset Management, L.P.
2.0%·$29M
Bank Of America Corp
1.1%·$16M
Price T Rowe Associates Inc
1.1%·$15,156
Northern Trust Corp
1.0%·$14M
Goldman Sachs Group Inc
0.5%·$8M
Jpmorgan Chase & Co
0.5%·$7M
Renaissance Technologies LLC
0.2%·$3M
Invesco Ltd.
0.1%·$1M
Free Float
77.8%

Sources: SEC filings

Notes: % shown as share of total shares outstanding · Free float = shares outstanding minus all known 13F institutional holdings

What Atlas covers for PROCEPT BioRobotics Corp
OverviewPROCEPT BioRobotics Corp share price history (10 years), key market statistics, and institutional shareholder structure from SEC 13F-HR filings.Business ModelHow PROCEPT BioRobotics Corp generates revenue — product and service segments, geographic breakdown, key operating metrics, and 10-year business evolution sourced from SEC filings.FinancialsPROCEPT BioRobotics Corp's complete financial history — 10 years of annual revenue, gross margins, operating income, net income, EPS, and free cash flow from SEC filings, plus 12 quarters of quarterly results.Management QualityPROCEPT BioRobotics Corp executive team profiles, insider buying and selling from SEC Form 4, earnings call transcripts, and a track record of guidance delivery vs actual results.Risk FactorsPROCEPT BioRobotics Corp's annual risk disclosures from SEC filings — full text, 5-year evolution showing how risks have shifted, and year-on-year delta highlighting new and removed risks.NewsAI-synthesised news digest for PROCEPT BioRobotics Corp, updated regularly with key developments, earnings updates, product announcements, and material company events.SentimentInvestor sentiment for PROCEPT BioRobotics Corp aggregated from X.com, Reddit, and Hacker News — discussion themes, Bull and Bear signals, and community analysis.Valuation & PeersPROCEPT BioRobotics Corp valuation multiples — P/E, EV/Revenue, EV/EBITDA — compared against a curated set of industry peers using live data from SEC filings. Custom peer selection available.DCF BuilderBuild a discounted cash flow model for PROCEPT BioRobotics Corp with 10 years of pre-filled revenue, margins, and cash flow data from SEC filings. Adjust growth rates, WACC, and terminal assumptions.Atlas AnalysisAtlas AI research synthesis for PROCEPT BioRobotics Corp — business model, financial health, management quality, risk profile, and institutional ownership, grounded exclusively in SEC filings.

Unlock the full analysis

9-tab institutional research sourced directly from SEC filings. No tips, no scores — the same process professional investors use.

7-day free trial · Plus & Pro · No charge during trial